Two-Year Results Support Medtronic’s Harmony Transcatheter Pulmonary Valve System
Medtech Insight's Cardiovascular Catch-Up highlights recent news on cardiovascular devices and innovations that you may have missed. This edition covers the two-year results of an 86-patient study of Medtronic’s Harmony transcatheter pulmonary valve.
You may also be interested in...
Medtech Insight sat down with Nina Goodheart, the president of Medtronic’s structural heart and aortic operating unit, to learn more about her experience with the company during the pandemic, the company’s commitment to diversity and inclusion, and the future of structural heart technology.
The company pulled Harmony from the market about a year ago following six reports of the capsule at the end of its delivery catheter breaking.
The Harmony transcatheter pulmonary valve can be used to improve blood flow to the lungs in patients with severe pulmonary valve regurgitation as a result of a congenital malformation of the right ventricular outflow tract.